A Phase II study of olaparib in breast cancer patients: biological evaluation from a 'window of opportunity' trial.
暂无分享，去创建一个
D. Generali | L. Zanotti | A. Bottini | M. Cappelletti | G. Roviello | A. Ravelli | Angela Gobbi | C. Senti | C. Strina | G. Allevi | M. Dester | M. Milani | S. Aguggini | F. Gussago | A. Cocconi